Application no. and date | 15165133.8 (espacenet) (Federated) (European Patent Register), 20020605 | Patent/reg. no. and date | DK/EP 2940044, 20161116 | Publication date | 20151104 | Priority no. and date | US 296961 P, 20010608 | EP pub. no. and date |
EP 2940044 20151104 | Effective date | | Applicant/owner | AbbVie Biotechnology Ltd, Harbour Fiduciary Services Limited Thistle House 4 Burnaby Street Hamilton Pembroke HM 11 , BM | Applicant ref. no. | P81605832DK00E | Inventor | WEISS, Roberta, 936 Clover Hill Road
Wynnewood, PA 19096, US, Fischkoff, Steven A., 5 Canoe Brook Road
Short Hills, NJ 07078, US, Kempeni, Joachim, Gimmeldinger Strasse 75
67433 Neustadt, DE | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | Opponent | | IPC Class | A61K 31/519 (2006.01) , A61K 39/395 (2006.01) , A61P 19/02 (2006.01) | Title | ANTI-TNF-ALFA-ANTISTOFFER TIL ANVENDELSE I TERAPI | Int. application no. | | Int. publication no. | | Related patent (certificate) | | Status | Udløbet | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|